2024 Q4 Form 10-Q Financial Statement

#000143774924033966 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $10.01M
YoY Change 8.39%
Cost Of Revenue $1.621M
YoY Change 80.75%
Gross Profit $8.389M
YoY Change 0.61%
Gross Profit Margin 83.81%
Selling, General & Admin $4.823M
YoY Change -19.62%
% of Gross Profit 57.49%
Research & Development $3.025M
YoY Change -17.09%
% of Gross Profit 36.05%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $7.847M
YoY Change -18.66%
Operating Profit $542.1K
YoY Change -141.4%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.331M
YoY Change 50.65%
Pretax Income $1.873M
YoY Change -539.48%
Income Tax $528.6K
% Of Pretax Income 28.23%
Net Earnings $1.344M
YoY Change -441.91%
Net Earnings / Revenue 13.43%
Basic Earnings Per Share $0.02
Diluted Earnings Per Share $0.02
COMMON SHARES
Basic Shares Outstanding 71.40M 71.37M
Diluted Shares Outstanding 71.77M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $99.27M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $62.02M
Prepaid Expenses
Receivables $12.09M
Other Receivables
Total Short-Term Assets $180.7M
YoY Change 23.78%
LONG-TERM ASSETS
Property, Plant & Equipment $1.411M
YoY Change -3.95%
Goodwill $898.3K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $253.6K
YoY Change -88.18%
Total Long-Term Assets $14.67M
YoY Change 18.19%
TOTAL ASSETS
Total Short-Term Assets $180.7M
Total Long-Term Assets $14.67M
Total Assets $195.4M
YoY Change 23.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.261M
YoY Change 123.43%
Accrued Expenses $7.185M
YoY Change -76.15%
Deferred Revenue $13.73M
YoY Change -37.31%
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $22.30M
YoY Change -27.46%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $22.30M
Total Long-Term Liabilities
Total Liabilities $25.91M
YoY Change -24.32%
SHAREHOLDERS EQUITY
Retained Earnings -$68.60M
YoY Change -38.31%
Common Stock $238.0M
YoY Change 1.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $169.4M
YoY Change
Total Liabilities & Shareholders Equity $195.4M
YoY Change 23.34%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $1.344M
YoY Change -441.91%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001010086
dei Entity Registrant Name
EntityRegistrantName
Siga Technologies INC
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71369274
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71369274
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71091616
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71091616
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
400000 usd
CY2024Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.6
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.6
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.45
CY2024Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
200000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
500000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilities
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-23047
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3864870
dei Entity Address Address Line1
EntityAddressAddressLine1
31 East 62nd Street
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10065
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
672-9100
dei Security12b Title
Security12bTitle
common stock, $.0001 par value
dei Trading Symbol
TradingSymbol
SIGA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71404669
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99269756 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150145844 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12089010 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21130951 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
62024473 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
64218337 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7302979 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3496028 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
180686218 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
238991160 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1411315 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1331708 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12104765 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11048118 usd
CY2024Q3 us-gaap Goodwill
Goodwill
898334 usd
CY2023Q4 us-gaap Goodwill
Goodwill
898334 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
253605 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2083535 usd
CY2024Q3 us-gaap Assets
Assets
195354237 usd
CY2023Q4 us-gaap Assets
Assets
254352855 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1260762 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1456316 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7184514 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10181810 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
13729440 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
20788720 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
127815 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
21690899 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
22302531 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
54117745 usd
CY2024Q3 us-gaap Other Liabilities
OtherLiabilities
3609572 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
3376203 usd
CY2024Q3 us-gaap Liabilities
Liabilities
25912103 usd
CY2023Q4 us-gaap Liabilities
Liabilities
57493948 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
7137 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
7109 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
238033324 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
235795420 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68598327 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38943622 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
169442134 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
196858907 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
195354237 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
254352855 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10009781 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9235171 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57250527 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23436361 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1620510 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
896537 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17157508 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3021145 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4822591 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5999761 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18228786 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14660828 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3024593 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3648117 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8966905 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13810307 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
9467694 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
10544415 usd
us-gaap Costs And Expenses
CostsAndExpenses
44353199 usd
us-gaap Costs And Expenses
CostsAndExpenses
31492280 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
542087 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1309244 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
12897328 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8055919 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1330505 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
883148 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4590935 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2964482 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1872592 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-426096 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17488263 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5091437 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
528647 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-33030 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4034362 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-904638 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1343945 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-393066 usd
us-gaap Net Income Loss
NetIncomeLoss
13453901 usd
us-gaap Net Income Loss
NetIncomeLoss
-4186799 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71368585
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71084735
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71191019
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71453397
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71766503
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71084735
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71853341
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71453397
us-gaap Net Income Loss
NetIncomeLoss
13453901 usd
us-gaap Net Income Loss
NetIncomeLoss
-4186799 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
407692 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
400702 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2876071 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1589993 usd
siga Inventory Write Down Net Of Credits
InventoryWriteDownNetOfCredits
327373 usd
siga Inventory Write Down Net Of Credits
InventoryWriteDownNetOfCredits
562941 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1056647 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1647191 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7059280 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
10240000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9041941 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-37356901 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2676093 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26240079 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2992590 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1433011 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3659762 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
379384 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-21563085 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1255240 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7548293 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15767601 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
24612 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
21686 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24612 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21686 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
638139 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
214794 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11072511 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
42665044 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
32135118 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43303183 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43422423 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-50876088 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-27676508 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150145844 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98790622 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99269756 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71114114 usd
siga Noncash Lease Rightofuse Assets And Liabilities Assumed Net Of Deferred Rent Expense
NoncashLeaseRightofuseAssetsAndLiabilitiesAssumedNetOfDeferredRentExpense
462686 usd
siga Noncash Lease Rightofuse Assets And Liabilities Assumed Net Of Deferred Rent Expense
NoncashLeaseRightofuseAssetsAndLiabilitiesAssumedNetOfDeferredRentExpense
0 usd
us-gaap Stock Issued1
StockIssued1
417000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
siga Stock Issued Upon Cashless Exercise
StockIssuedUponCashlessExercise
0 usd
siga Stock Issued Upon Cashless Exercise
StockIssuedUponCashlessExercise
87540 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
174200000 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2800000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
7100000 usd
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
134535 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8061800 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
51422661 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
53649859 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10467277 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2506678 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
62024473 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
64218337 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7344410 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6914657 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5933095 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5582949 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1411315 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1331708 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
400000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2232903 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2477619 usd
CY2024Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2101043 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2974863 usd
CY2024Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1309923 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3300985 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
686767 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
445653 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
535234 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
564009 usd
CY2024Q3 siga Accrued Research And Development Vendor Costs Current
AccruedResearchAndDevelopmentVendorCostsCurrent
318644 usd
CY2023Q4 siga Accrued Research And Development Vendor Costs Current
AccruedResearchAndDevelopmentVendorCostsCurrent
418681 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7184514 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10181810 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1343945 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-393066 usd
us-gaap Net Income Loss
NetIncomeLoss
13453901 usd
us-gaap Net Income Loss
NetIncomeLoss
-4186799 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71368585
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71084735
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71191019
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71453397
CY2024Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
397918
CY2023Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
662322
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71766503
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71084735
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71853341
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71453397
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40075
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
51518
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
59312
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42238
CY2024Q3 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
3300000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10009781 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9235171 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57250527 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23436361 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
17500000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-5100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-900000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.231 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.178 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
167558549 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1343945 usd
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q3 siga Dividends On Common Stock Cash
DividendsOnCommonStockCash
8466 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
813774 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
169442134 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
196858907 usd
us-gaap Net Income Loss
NetIncomeLoss
13453901 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
638139 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
siga Dividends On Common Stock Cash
DividendsOnCommonStockCash
-43108606 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2876071 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
169442134 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
124074056 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-393066 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
459823 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
124140813 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
170160042 usd
us-gaap Net Income Loss
NetIncomeLoss
-4186799 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
11072511 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
214794 usd
siga Dividends On Common Stock Cash
DividendsOnCommonStockCash
-32135118 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1589993 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
124140813 usd
CY2021Q3 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1700000
siga Stock Repurchased During Period Value Gross
StockRepurchasedDuringPeriodValueGross
11000000 usd
siga Excise Tax On Corporate Shares Repurchased
ExciseTaxOnCorporateSharesRepurchased
100000 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
200000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
100000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
500000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
400000 usd
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
200000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
500000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y5M23D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0995 pure
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
113547 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
683213 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
686190 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
165916 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1648866 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
142042 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1506824 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1000000 usd

Files In Submission

Name View Source Status
0001437749-24-033966-index-headers.html Edgar Link pending
0001437749-24-033966-index.html Edgar Link pending
0001437749-24-033966.txt Edgar Link pending
0001437749-24-033966-xbrl.zip Edgar Link pending
ex_707711.htm Edgar Link pending
ex_707712.htm Edgar Link pending
ex_707713.htm Edgar Link pending
ex_707714.htm Edgar Link pending
ex_734039.htm Edgar Link pending
ex_734040.htm Edgar Link pending
ex_734041.htm Edgar Link pending
ex_734042.htm Edgar Link pending
ex_734043.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
siga-20240930.xsd Edgar Link pending
siga20240930_10q.htm Edgar Link pending
siga-20240930_cal.xml Edgar Link unprocessable
siga-20240930_def.xml Edgar Link unprocessable
siga-20240930_lab.xml Edgar Link unprocessable
siga-20240930_pre.xml Edgar Link unprocessable
siga20240930_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable